Structural and functional characterization of an atypical activation domain in erythroid Krüppel-like factor (EKLF)

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 26, 2011, Pages 10484-10489

  Mas, Caroline ^a   Lussier Price, Mathieu ^a   Soni, Shefali ^b   Morse, Thomas ^a   Arseneault, Geneviève ^a   Di Lello, Paola ^a   Lafrance Vanasse, Julien ^a   Bieker, James J ^b   Omichinski, James G ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Hematopoiesis; Intrinsically unstructured domain; NMR spectroscopy; Transcription factor IIE; Transcriptional activators

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ERYTHROID KRUPPEL LIKE FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; HUMAN; HUMAN CELL; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; BINDING SITES; CALORIMETRY; CLONING, MOLECULAR; HUMANS; K562 CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS;

EID: 79960600766     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1017029108     Document Type: Article

References (48)

1. Bieker JJ (2001) Kruppel-like factors: Three fingers in many pies. J Biol Chem 276:34355-34358.
2. Kaczynski J, Cook T, Urrutia R (2003) Sp1- and Kruppel-like transcription factors. Genome Biol 4(2):206.
3. Miller IJ, Bieker JJ (1993) A novel, erythroid cell-specific murine transcription factor that binds the CACCC element and is related to the Kruppel family of nuclear proteins. Mol Cell Biol 13:2776-2786. (Pubitemid 23133950)
4. Hodge D, et al. (2006) A global role for EKLF in definitive and primitive erythropoiesis. Blood 107:3359-3370.
5. Perkins AC, Sharpe AH, Orkin SH (1995) Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 375:318-322.
6. Nuez B, Michalovich D, Bygrave A, Ploemacher R, Grosveld F (1995) Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 375 (6529):316-318.
7. Wijgerde M, et al. (1996) The role of EKLF in human beta-globin gene competition. Genes Dev 10:2894-2902. (Pubitemid 26394249)
8. Borg J, et al. (2010) Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet 42(9):801-U100.
9. Zhou DW, Liu KM, Sun CW, Pawlik KM, Townes TM (2010) KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching. Nat Genet 42(9):742-744.
10. Feng WC, Southwood CM, Bieker JJ (1994) Analyses of beta-thalassemia mutant DNA interactions with erythroid Kruppel-like factor (EKLF), an erythroid cell-specific transcription factor. J Biol Chem 269:1493-1500.
11. Chen XY, Bieker JJ (2004) Stage-specific repression by the EKLF transcriptional activator. Mol Cell Biol 24:10416-10424.
12. Zhang W, Bieker JJ (1998) Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc Natl Acad Sci USA 95:9855-9860.
13. Zhang W, Kadam S, Emerson BM, Bieker JJ (2001) Site-specific acetylation by p300 or CREB binding protein regulates erythroid Kruppel-like factor transcriptional activity via its interaction with the SWI-SNF complex. Mol Cell Biol 21:2413-2422. (Pubitemid 32222094)
14. Sengupta T, Chen K, Milot E, Bieker JJ (2008) Acetylation of EKLF is essential for epigenetic modification and transcriptional activation of the beta-globin locus. Mol Cell Biol 28:6160-6170.
15. Bottardi S, Ross J, Pierre-Charles N, Blank V, Milot E (2006) Lineage-specific activators affect beta-globin locus chromatin in multipotent hematopoietic progenitors. EMBO J 25:3586-3595. (Pubitemid 44264869)
16. Sengupta T, Cohet N, Morle F, Bieker JJ (2009) Distinct modes of gene regulation by a cell-specific transcriptional activator. Proc Natl Acad Sci USA 106:4213-4218.
17. Chen X, Bieker JJ (1996) Erythroid Krueppel-like factor (EKLF) contains a multifunctional transcriptional activation domain important for inter- and intramolecular interactions. EMBO J 15:5888-5896. (Pubitemid 26375510)
18. Ouyang L, Chen X, Bieker JJ (1998) Regulation of erythroid Kruppel-like factor (EKLF) transcriptional activity by phosphorylation of a protein kinase casein kinase II site within its interaction domain. J Biol Chem 273:23019-23025. (Pubitemid 28417480)
19. Fields S, Jang SK (1990) Presence of a potent transcription activating sequence in the p53 protein. Science 249:1046-1049.
20. Cress WD, Triezenberg SJ (1991) Critical structural elements of the VP16 transcriptional activation domain. Science 251:87-90. (Pubitemid 21916859)
21. Sullivan SM, et al. (1998) Mutational analysis of a transcriptional activation region of the VP16 protein of herpes simplex virus. Nucleic Acids Res 26:4487-4496. (Pubitemid 28442144)
22. Candau R, et al. (1997) Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity. Oncogene 15:807-816. (Pubitemid 27390133)
23. Kussie PH, et al. (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor supressor transactivation domain. Science 274:948-953. (Pubitemid 26398409)
24. Ferreon JC, et al. (2009) Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2. Proc Natl Acad Sci USA 106:6591-6596.
25. Teufel DP, Freund SM, Bycroft M, Fersht AR (2007) Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc Natl Acad Sci USA 104:7009-7014. (Pubitemid 47186000)
26. Langlois C, et al. (2008) NMR structure of the complex between the Tfb1 subunit of TFIIH and the activation domain of VP16: Structural similarities between VP16 and p53. J Am Chem Soc 130:10596-10604.
27. Di Lello P, et al. (2006) Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol Cell 22:731-740.
28. Glover-Cutter K, et al. (2009) TFIIH-associated Cdk7 kinase functions in phosphorylation of C-terminal domain Ser7 residues, promoter-proximal pausing, and termination by RNA polymerase II. Mol Cell Biol 29:5455-5464.
29. Bird G, Zorio DAR, Bentley DL (2004) RNA polymerase II carboxy-terminal domain phosphorylation is required for cotranscriptional pre-mRNA splicing and 3'-end formation. Mol Cell Biol 24:8963-8969. (Pubitemid 39313901)
30. Viprakasit V, et al. (2001) Mutations in the general transcription factor TFIIH result in beta-thalassaemia in individuals with trichothiodystrophy. Hum Mol Genet 10:2797-2802. (Pubitemid 34026461)
31. Avantaggiati ML, et al. (1997) Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175-1184. (Pubitemid 127678750)
32. Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595-606. (Pubitemid 27357952)
33. Di Lello P, et al. (2005) NMR structure of the amino-terminal domain from the Tfb1 subunit of TFIIH and characterization of its phosphoinositide and VP16 binding sites. Biochemistry 44:7678-7686. (Pubitemid 40740751)
34. Pandya K, Donze D, Townes TM (2001) Novel transactivation domain in erythroid Kruppel-like factor (EKLF). J Biol Chem 276:8239-8243.
35. Brown RC, et al. (2002) Distinct domains of erythroid Kruppel-like factor modulate chromatin remodeling and transactivation at the endogenous beta-globin gene promoter. Mol Cell Biol 22:161-170.
36. Wojciak JM, Martinez-Yamout MA, Dyson HJ, Wright PE (2009) Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains. EMBO J 28:948-958.
37. Ferreon JC, Martinez-Yamout MA, Dyson HJ, Wright PE (2009) Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein. Proc Natl Acad Sci USA 106:13260-13265.
38. De Guzman RN, Martinez-Yamout MA, Dyson HJ, Wright PE (2004) Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: Regulation by competition between intrinsically unstructured ligands for nonidentical binding sites. J Biol Chem 279:3042-3049. (Pubitemid 38114297)
39. Okuda M, et al. (2008) Structural insight into the TFIIE-TFIIH interaction: TFIIE and p53 share the binding region on TFIIH. EMBO J 27:1161-1171. (Pubitemid 351508156)
40. Di Lello P, et al. (2008) p53 and TFIIEalpha share a common binding site on the Tfb1/p62 subunit of TFIIH. Proc Natl Acad Sci USA 105:106-111.
41. Dames SA, Martinez-Yamout M, De Guzman RN, Dyson HJ,Wright PE (2002) Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response. Proc Natl Acad Sci USA 99:5271-5276. (Pubitemid 34411538)
42. SenBanerjee S, et al. (2004) KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 199:1305-1315. (Pubitemid 38685723)
43. Evans PM, et al. (2007) Krurppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J Biol Chem 282:33994-34002. (Pubitemid 350159428)
44. Zhang ZP, Teng CT (2003) Phosphorylation of Kruppel-like factor 5 (KLF5/IKLF) at the CBP interaction region enhances its transactivation function. Nucleic Acids Res 31:2196-2208.
45. Hussain S, Lara-Pezzi E, Brand N (2008) Role of the KLF15 transcription factor in an anti-hypertrophic pathway involving GSK3 beta. Heart 94:A53-A54.
46. Cornilescu G, Delaglio F, Bax A (1999) Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR 13:289-302. (Pubitemid 29143535)
47. Brunger AT, et al. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54:905-921.
48. Siatecka M, Xue L, Bieker JJ (2007) Sumoylation of EKLF promotes transcriptional repression and is involved in inhibition of megakaryopoiesis. Mol Cell Biol 27:8547-8560.